National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

yttrium Y 90 monoclonal antibody MN-14
A radioimmunotherapeutic monoclonal antibody (MN-14) directed against tumor-associated carcinoembryonic antigen (CEA) and chelated to the radioisotope yttrium-90 (Y 90). Y 90 monoclonal antibody MN-14 binds to tumor cell expressing CEA, delivering a cytotoxic dose of beta radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Y 90 Monoclonal Antibody MN-14
yttrium Y 90 MOAB MN-14
Abbreviation:Y 90 MoAb MN-14



Previous:yttrium Y 90 humanized epratuzumab, yttrium Y 90 ibritumomab tiuxetan, yttrium Y 90 monoclonal antibody B3, yttrium Y 90 monoclonal antibody BrE-3, yttrium Y 90 monoclonal antibody Hu3S193
Next:yttrium Y 90 resin microspheres, yttrium Y 90-DOTA-chimeric monoclonal antibody cG250, yttrium Y 90-edotreotide, Z-360, Zactima

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov